For the company, which currently works with hospitals in over 30 countries, the award also marks a shift in its continued growth journey.

Related article

The winners at Swecare Export Award 2026

Encare will be awarded the Swecare Export Award 2026 and Bioservo will be named a Rising Star.


A new phase

The jury particularly pointed to the combination of an evidence-based solution, international collaborations and strong reference customers, not least in the USA. The company has long built an international presence and today works with several of the world’s leading hospitals, including Mayo Clinic and Kaiser Permanente in the USA, as well as Karolinska University Hospital in Sweden.

At the same time, the company is entering a new phase. The international model is already established and proven, and work is continuing to scale it in a more targeted manner and with clearer priorities. The US has thus become the central market in the next phase.

“The US is our most important expansion market. It is the world’s largest surgical market and at the same time the market that is moving fastest towards value-based reimbursement, for example the CMS TEAM model that will come into effect in 2026 and which directly links hospitals’ reimbursement to complication rates,” says Rasmus Waller, CEO, Encare. “The next concrete step is to expand our US presence – both the commercial team and the local customer organization – and to translate our Mayo Clinic base into a broader foothold in several US hospitals.”